Zelira Therapeutics Limited
ZLDAF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $4,929 | $7,020 | $3,965 | $9,819 |
| - Cash | $6 | $38 | $586 | $65 |
| + Debt | $2,141 | $6,303 | $5,949 | $1,725 |
| Enterprise Value | $7,065 | $13,285 | $9,328 | $11,479 |
| Revenue | $0 | $1 | $40 | $55 |
| % Growth | -100% | -98.4% | -26.5% | – |
| Gross Profit | -$801 | -$2 | -$283 | -$1,105 |
| % Margin | – | -321.7% | -703.7% | -2,019.3% |
| EBITDA | -$2,677 | -$1,374 | -$2,606 | -$33,835 |
| % Margin | – | -209,712.4% | -6,478.3% | -61,829.6% |
| Net Income | -$1,217 | -$2,411 | -$2,434 | -$34,135 |
| % Margin | – | -368,036.5% | -6,050.5% | -62,377.5% |
| EPS Diluted | -0.1 | -0.21 | -0.21 | -3.01 |
| % Growth | 52.4% | 0% | 93% | – |
| Operating Cash Flow | -$2,275 | -$2,632 | -$2,656 | -$1,732 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2,275 | -$2,632 | -$2,656 | -$1,732 |